BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 15245535)

  • 1. Psoralen plus ultraviolet A irradiation-induced lentigines arising in vitiligo: involvement of vitiliginous and normal appearing skin.
    Abdel Naser MB; Wollina U; El Okby M; El Shiemy S
    Clin Exp Dermatol; 2004 Jul; 29(4):380-2. PubMed ID: 15245535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic cutaneous effects of long-term psoralen and ultraviolet radiation therapy in patients with vitiligo.
    Harrist TJ; Pathak MA; Mosher DB; Fitzpatrick TB
    Natl Cancer Inst Monogr; 1984 Dec; 66():191-6. PubMed ID: 6531028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical pigmented lesions following extensive PUVA therapy.
    Basarab T; Millard TP; McGregor JM; Barker JN
    Clin Exp Dermatol; 2000 Mar; 25(2):135-7. PubMed ID: 10733639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.
    Westerhof W; Nieuweboer-Krobotova L
    Arch Dermatol; 1997 Dec; 133(12):1525-8. PubMed ID: 9420536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
    Parsad D; Kanwar AJ; Kumar B
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photochemotherapy-induced lentigines on a vitiliginous patch. Electron microscopic observations.
    Lee KH; Bang D; Lee WS
    Yonsei Med J; 1988; 29(1):66-71. PubMed ID: 3381548
    [No Abstract]   [Full Text] [Related]  

  • 7. PUVA-induced melanocytic atypia: is it confined to PUVA lentigines?
    Abel EA; Reid H; Wood C; Hu CH
    J Am Acad Dermatol; 1985 Nov; 13(5 Pt 1):761-8. PubMed ID: 4078071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple keratoses and squamous carcinoma after PUVA treatment of vitiligo.
    Buckley DA; Rogers S
    Clin Exp Dermatol; 1996 Jan; 21(1):43-5. PubMed ID: 8689768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo.
    Wu CS; Lan CC; Wang LF; Chen GS; Wu CS; Yu HS
    Br J Dermatol; 2007 Jan; 156(1):122-9. PubMed ID: 17199578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo.
    Arca E; Taştan HB; Erbil AH; Sezer E; Koç E; Kurumlu Z
    J Dermatol; 2006 May; 33(5):338-43. PubMed ID: 16700666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryotherapy of PUVA lentigines.
    Leroy D; Dompmartin A; Dubreuil A; Louvet S
    Br J Dermatol; 1996 Dec; 135(6):988-90. PubMed ID: 8977725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative morphometric study of eruptive PUVA-induced and chronic sun-induced lentigines of the skin.
    Nikkels A; Ben Mosbah T; Piérard-Franchimont C; de la Brassinne M; Piérard GE
    Anal Quant Cytol Histol; 1991 Feb; 13(1):23-6. PubMed ID: 2025370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcipotriol and PUVA as treatment for vitiligo.
    Cherif F; Azaiz MI; Ben Hamida A; Ben O; Dhari A
    Dermatol Online J; 2003 Dec; 9(5):4. PubMed ID: 14996377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches.
    Parsad D; Pandhi R; Dogra S; Kumar B
    J Am Acad Dermatol; 2004 Jan; 50(1):63-7. PubMed ID: 14699367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localized vitiligo successfully treated with cream-psoralen + ultraviolet A.
    Kreuter A; Gambichler T; Avermaete A; Jansen T; Altmeyer P; von Kobyletzki G
    J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):357-8. PubMed ID: 11730053
    [No Abstract]   [Full Text] [Related]  

  • 16. Endothelin-1 is significantly elevated in plasma of patients with vitiligo treated with psoralen plus ultraviolet A.
    Abdel-Naser MB; El-Khateeb EA; Sallam TH; Habib MA
    Clin Exp Dermatol; 2006 Jul; 31(4):571-5. PubMed ID: 16716165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term effects of PUVA therapy on Israeli patients with vitiligo].
    Vussuki E; Ziv M; Rosenman D; David M
    Harefuah; 2006 Jul; 145(7):483-5, 552, 551. PubMed ID: 16900734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PUVA therapy.
    Helm TN; Dijkstra JW; Ferrara RJ; Glanz S
    Am Fam Physician; 1991 Mar; 43(3):908-12. PubMed ID: 2000735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acral PUVA--induced pigmented macules.
    Cruz A; Sánchez JL
    Bol Asoc Med P R; 1990 Oct; 82(10):460-2. PubMed ID: 2080960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
    Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.